Arrestin-3-assisted activation of JNK3 mediates dopaminergic behavioral sensitization

Mohamed R Ahmed1, Chen Zheng2, Jeffery L Dunning3

  • 1Department of Pharmacology, Vanderbilt University, 2200 Pierce Avenue, PRB422, Nashville, TN 37232, USA; University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA; The University of Alabama at Birmingham, SHEL 121, 1825 University Boulevard, Birmingham, AL 35294-2182, USA.

PubMed

Insights

Arrestin-3 protein is crucial for behavioral sensitization in mice treated with L-DOPA after dopamine depletion. Restoring arrestin-3, specifically its ability to activate c-Jun N-terminal kinase (JNK), fully rescues this sensitization.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • L-DOPA treatment in dopamine-depleted rodents causes behavioral sensitization.
  • This sensitization is impaired in arrestin-3 knockout mice.

Purpose of the Study:

  • To investigate the role of arrestin-3 in L-DOPA-induced behavioral sensitization.
  • To determine if arrestin-3's ability to activate c-Jun N-terminal kinase (JNK) is essential for this process.

Main Methods:

  • Utilized virus-mediated gene delivery in arrestin-3 knockout mice with dopamine-depleted striatum.
  • Restored arrestin-3 or its JNK-activating peptide in striatal neurons.
  • Assessed behavioral sensitization and JNK3 activity via c-Jun phosphorylation.

Main Results:

  • Restoration of arrestin-3 fully rescued behavioral sensitization.
  • A mutant arrestin-3 defective in JNK activation did not rescue sensitization.
  • An arrestin-3-derived peptide facilitating JNK3 activation rescued sensitization, unlike an arrestin-2 peptide.

Conclusions:

  • Arrestin-3 is essential for L-DOPA-induced behavioral sensitization.
  • Arrestin-3-mediated activation of JNK3 in direct pathway striatal neurons is a key molecular mechanism underlying sensitization.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K